Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Allergy ; 2024 Aug 19.
Artículo en Inglés | MEDLINE | ID: mdl-39157907

RESUMEN

BACKGROUND: The field of drug development is witnessing a remarkable surge in the development of innovative strategies. There is a need to develop technological platforms capable of generating human data prior to progressing to clinical trials. METHODS: Here we introduce a new flexible solution designed for the comprehensive monitoring of the natural human skin ecosystem's response to immunogenic drugs over time. Based on unique bioengineering to preserve surgical resections in a long survival state, it allows for the first time a comprehensive analysis of resident immune cells response at both organ and single-cell levels. RESULTS: Upon injection of the mRNA-1273 COVID-19 vaccine, we characterized precise sequential molecular events triggered upon detection of the exogenous substance. The vaccine consistently targets DC/macrophages and mast cells, regardless of the administration route, while promoting specific cell-cell communications in surrounding immune cell subsets. CONCLUSION: Given its direct translational relevance, this approach provides a multiscale vision of genuine human tissue immunity that could pave the way toward the development of new vaccination and drug development strategies.

2.
Exp Dermatol ; 29(10): 993-1003, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-32737987

RESUMEN

Skin models mimicking features of psoriasis-related inflammation are needed to support the development of new drugs in dermatology. Reconstructed skin models lack tissue complexity, including a fully competent skin barrier, and presence and/or diversity of immune cells. Here, we describe InflammaSkin®, a novel human Th17-driven ex vivo skin inflammation model. In this model, skin-resident T cells are in situ activated by intradermal injection of anti-CD3 and anti-CD28 antibodies and Th17 cell polarization is sustained by culture in a chemically defined medium supplemented with IL-1ß, IL-23 and TGF-ß for seven days. The acquired Th17 signature is demonstrated by the sustained secretion of IL-17A, IL-17AF, IL-17F, IL-22, IFN-γ, and to some degree IL-15 and TNF-α observed in the activated ex vivo skin inflammation model compared with the non-activated skin model control. Furthermore, expression of S100A7 and Keratin-16 by keratinocytes and loss of epidermal structure integrity occur subsequently to in situ Th17cell activation, demonstrating cellular crosstalk between Th17 cells and keratinocytes. Finally, we demonstrate the use of this model to investigate the modulation of the IL-23/IL-17 immune axis by topically applied anti-inflammatory compounds. Taken together, we show that by in situ activation of skin-resident Th17 cells, the InflammaSkin® model reproduces aspects of inflammatory responses observed in psoriatic lesions and could be used as a translational tool to assess efficacy of test compounds.


Asunto(s)
Dermatitis/inmunología , Activación de Linfocitos , Modelos Biológicos , Células Th17/inmunología , Antiinflamatorios/uso terapéutico , Anticuerpos , Betametasona/análogos & derivados , Betametasona/uso terapéutico , Antígenos CD28/inmunología , Complejo CD3/inmunología , Comunicación Celular , Medios de Cultivo , Dermatitis/tratamiento farmacológico , Humanos , Interferón gamma/metabolismo , Interleucina-15/metabolismo , Interleucina-17/metabolismo , Interleucinas/metabolismo , Queratina-16/metabolismo , Queratinocitos/metabolismo , Inhibidores de Fosfodiesterasa 4/uso terapéutico , Proteína A7 de Unión a Calcio de la Familia S100/metabolismo , Células Th17/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Interleucina-22
3.
Gastroenterology ; 154(4): 1009-1023.e14, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29133078

RESUMEN

BACKGROUND & AIMS: Paneth cell dysfunction causes deficiencies in intestinal C-type lectins and antimicrobial peptides, which leads to dysbiosis of the intestinal microbiota, alters the mucosal barrier, and promotes development of inflammatory bowel diseases. We investigated whether transgenic (TG) expression of the human regenerating family member 3 alpha gene (REG3A) alters the fecal microbiota and affects development of colitis in mice. METHODS: We performed studies with C57BL/6 mice that express human regenerating family member 3 alpha (hREG3A) in hepatocytes, via the albumin gene promoter. In these mice, hREG3A travels via the bile to the intestinal lumen. Some mice were given dextran sodium sulfate (DSS) to induce colitis. Feces were collected from mice and the composition of the microbiota was analyzed by 16S ribosomal RNA sequencing. The fecal microbiome was also analyzed from mice that express only 1 copy of human REG3A transgene but were fed feces from control mice (not expressing hREG3A) as newborns. Mice expressing hREG3A were monitored for DSS-induced colitis after cohousing or feeding feces from control mice. Colitis was induced in another set of control and hREG3A-TG mice by administration of trinitrobenzene sulfonic acid; some mice were given intrarectal injections of the hREG3A protein. Colon tissues were collected from mice and analyzed by histology and immunohistochemistry to detect mucin 2, as well as by 16S ribosomal RNA fluorescence in situ hybridization, transcriptional analyses, and quantitative polymerase chain reaction. We measured levels of reactive oxygen species (ROS) in bacterial cultures and fecal microbiota using 2',7'-dichlorofluorescein diacetate and flow cytometry. RESULTS: The fecal microbiota of mice that express hREG3A had a significant shift in composition, compared with control mice, with enrichment of Clostridiales (Ruminococcaceae, Lachnospiraceae) and depletion of Bacteroidetes (Prevotellaceae); the TG mice developed less-severe colitis following administration of DSS than control mice, associated with preserved gut barrier integrity and reduced bacterial translocation, epithelial inflammation, and oxidative damage. A similar shift in the composition of the fecal microbiota occurred after a few months in TG mice heterozygous for REG3A that harbored a wild-type maternal microbiota at birth; these mice developed less-severe forms of colitis following DSS administration. Cohoused and germ-free mice fed feces from REG3A-TG mice and given DSS developed less-severe forms of colitis and had reduced lipopolysaccharide activation of the toll-like receptor 4 and increased survival times compared with mice not fed feces from REG3A-TG mice. REG3A TG mice developed only mild colonic inflammation after exposure to 2,4,6-trinitrobenzene sulfonic acid, compared with control mice. Control mice given intrarectal hREG3A and exposed to 2,4,6-trinitrobenzene sulfonic acid showed less colon damage and inflammation than mice not given intrarectal hREG3A. Fecal samples from REG3A-TG mice had lower levels of ROS than feces from control mice during DSS administration. Addition of hREG3A to bacterial cultures reduced levels of ROS and increased survival of oxygen-sensitive commensal bacteria (Faecalibacterium prausnitzii and Roseburia intestinalis). CONCLUSIONS: Mice with hepatocytes that express hREG3A, which travels to the intestinal lumen, are less sensitive to colitis than control mice. We found hREG3A to alter the colonic microbiota by decreasing levels of ROS. Fecal microbiota from REG3A-TG mice protect non-TG mice from induction of colitis. These findings indicate a role for reduction of oxidative stress in preserving the gut microbiota and its ability to prevent inflammation.


Asunto(s)
Bacterias/metabolismo , Colitis/prevención & control , Colon/metabolismo , Microbioma Gastrointestinal , Hepatocitos/metabolismo , Proteínas Asociadas a Pancreatitis/metabolismo , Animales , Bacterias/clasificación , Bacterias/crecimiento & desarrollo , Colitis/inducido químicamente , Colitis/metabolismo , Colitis/microbiología , Colon/microbiología , Sulfato de Dextran , Modelos Animales de Enfermedad , Trasplante de Microbiota Fecal , Humanos , Ratones Endogámicos C57BL , Ratones Transgénicos , Viabilidad Microbiana , Estrés Oxidativo/efectos de los fármacos , Proteínas Asociadas a Pancreatitis/genética , Especies Reactivas de Oxígeno/metabolismo , Factores de Tiempo , Ácido Trinitrobencenosulfónico
4.
Genome Res ; 25(12): 1812-24, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26510915

RESUMEN

An increasing number of noncoding RNAs (ncRNAs) have been implicated in various human diseases including cancer; however, the ncRNA transcriptome of hepatocellular carcinoma (HCC) is largely unexplored. We used CAGE to map transcription start sites across various types of human and mouse HCCs with emphasis on ncRNAs distant from protein-coding genes. Here, we report that retroviral LTR promoters, expressed in healthy tissues such as testis and placenta but not liver, are widely activated in liver tumors. Despite HCC heterogeneity, a subset of LTR-derived ncRNAs were more than 10-fold up-regulated in the vast majority of samples. HCCs with a high LTR activity mostly had a viral etiology, were less differentiated, and showed higher risk of recurrence. ChIP-seq data show that MYC and MAX are associated with ncRNA deregulation. Globally, CAGE enabled us to build a mammalian promoter map for HCC, which uncovers a new layer of complexity in HCC genomics.


Asunto(s)
Carcinoma Hepatocelular/etiología , Perfilación de la Expresión Génica , Neoplasias Hepáticas/etiología , Regiones Promotoras Genéticas , ARN no Traducido/genética , Secuencias Repetidas Terminales , Sitio de Iniciación de la Transcripción , Subfamilia B de Transportador de Casetes de Unión a ATP/genética , Animales , Carcinoma Hepatocelular/patología , Línea Celular Tumoral , Transformación Celular Neoplásica/genética , Transformación Celular Viral , Biología Computacional/métodos , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Perfilación de la Expresión Génica/métodos , Regulación Neoplásica de la Expresión Génica , Humanos , Neoplasias Hepáticas/patología , Ratones , Ratones Noqueados , Unión Proteica , Factores de Transcripción/metabolismo , Transcriptoma , Miembro 4 de la Subfamilia B de Casete de Unión a ATP
5.
Mol Microbiol ; 100(1): 15-24, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26713511

RESUMEN

Using genetics and metabolomics we investigated the synthesis (gshA and gshB genes) and catabolism (ggt) of the conserved antioxidant glutathione in the model cyanobacterium Synechocystis PCC6803. These three genes are crucial to Synechocystis, in agreement with the proposed invention of glutathione by ancient cyanobacteria to protect themselves against the toxicity of oxygen they produced through photosynthesis. Consistent with their indispensability, gshA and gshB also operate in the production of another antioxidant, ergothioneine, as well as of the glutathione analogues ophthalmate and norophthalmate. Furthermore, we show that glutathione, ophthalmate and norophthalmate are accumulated in cells stressed by glucose, and that the two glutathione-dependent glyoxalase enzymes operate in the protection against glucose and its catabolite methylglyoxal. These findings are interesting because ophthalmate and norophthalmate were observed only in mammals so far, where ophthalmate is regarded as a biomarker of glutathione depletion. Instead, our data suggest that ophthalmate and norophthalmate are stress-induced markers of cysteine depletion triggered by its accelerated incorporation into glutathione, to face its increased demand for detoxification purposes. Hence, Synechocystis is an attractive model for the analysis of the role of glutathione, ergothioneine, ophthalmate and norophthalmate, in signalling and detoxification of oxidants and metabolic by-products.


Asunto(s)
Cianobacterias/metabolismo , Inactivación Metabólica , Estrés Oxidativo , Transducción de Señal , Vías Biosintéticas , Cianobacterias/genética , Cianobacterias/crecimiento & desarrollo , Ergotioneína/biosíntesis , Genes Bacterianos , Glucosa/metabolismo , Glutatión/biosíntesis , Lactoilglutatión Liasa/metabolismo , Oligopéptidos/biosíntesis , Piruvaldehído/metabolismo , Synechocystis/metabolismo
6.
Animals (Basel) ; 13(6)2023 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-36978561

RESUMEN

In the context of a growing population, beef production is expected to reduce its consumption of human-edible food and its contribution to global warming. We hypothesize that implementing the innovations of fast rotational grazing and redesigning existing production systems using crossbreeding and sexing may reduce these impacts. In this research, the bio-economic model FarmDyn is used to assess the impact of such innovations on farm profit, workload, global warming potential, and feed-food competition. The innovations are tested in a Belgian system composed of a Belgian Blue breeder and a fattener farm, another system where calves raised in a French suckler cow farm are fattened in a farm in Italy, and third, a German dairy farm that fattens its male calves. The practice of fast rotational grazing with a herd of dairy-to-beef crossbred males is found to have the best potential for greenhouse gas reduction and a reduction of the use of human-edible food when by-products are available. Crossbreeding with early-maturing beef breeds shows a suitable potential to produce grass-based beef with little feed-food competition if the stocking rate considers the grassland yield potential. The results motivate field trials in order to validate the findings.

7.
Sci Adv ; 9(23): eadf9491, 2023 06 09.
Artículo en Inglés | MEDLINE | ID: mdl-37285432

RESUMEN

Routine clinical assays, such as conventional immunohistochemistry, often fail to resolve the regional heterogeneity of complex inflammatory skin conditions. We introduce MANTIS (Multiplex Annotated Tissue Imaging System), a flexible analytic pipeline compatible with routine practice, specifically designed for spatially resolved immune phenotyping of the skin in experimental or clinical samples. On the basis of phenotype attribution matrices coupled to α-shape algorithms, MANTIS projects a representative digital immune landscape while enabling automated detection of major inflammatory clusters and concomitant single-cell data quantification of biomarkers. We observed that severe pathological lesions from systemic lupus erythematosus, Kawasaki syndrome, or COVID-19-associated skin manifestations share common quantitative immune features while displaying a nonrandom distribution of cells with the formation of disease-specific dermal immune structures. Given its accuracy and flexibility, MANTIS is designed to solve the spatial organization of complex immune environments to better apprehend the pathophysiology of skin manifestations.


Asunto(s)
COVID-19 , Lupus Eritematoso Sistémico , Humanos , COVID-19/patología , Piel
8.
BMJ Qual Saf ; 31(10): 716-724, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35428684

RESUMEN

BACKGROUND: Unrecognised changes in a hospitalised patient's clinical course may lead to a preventable adverse event. Early warning systems (EWS) use patient data, such as vital signs, nursing assessments and laboratory values, to aid in the detection of early clinical deterioration. In 2018, an EWS programme was deployed at an academic hospital that consisted of a commercially available EWS algorithm and a centralised virtual nurse team to monitor alerts. Our objective was to understand the nursing perspective on the use of an EWS programme with centralised monitoring. METHODS: We conducted and audio-recorded semistructured focus groups during nurse staff meetings on six inpatient units, stratified by alert frequency (high: >100 alerts/month; medium: 50-100 alerts/month; low: <50 alerts/month). Discussion topics included EWS programme experiences, perception of EWS programme utility and EWS programme implementation. Investigators analysed the focus group transcripts using a grounded theory approach. RESULTS: We conducted 28 focus groups with 227 bedside nurses across all shifts. We identified six principal themes: (1) Alert timeliness, nurses reported being aware of the patient's deterioration before the EWS alert, (2) Lack of accuracy, nurses perceived most alerts as false positives, (3) Workflow interruptions caused by EWS alerts, (4) Questions of actionability of alerts, nurses were often uncertain about next steps, (5) Concerns around an underappreciation of core nursing skills via reliance on the EWS programme and (6) The opportunity cost of deploying the EWS programme. CONCLUSION: This qualitative study of nurses demonstrates the importance of earning user trust, ensuring timeliness and outlining actionable next steps when implementing an EWS. Careful attention to user workflow is required to maximise EWS impact on improving hospital quality and patient safety.


Asunto(s)
Deterioro Clínico , Grupos Focales , Humanos , Monitoreo Fisiológico , Investigación Cualitativa , Signos Vitales
9.
Female Pelvic Med Reconstr Surg ; 26(7): 425-430, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32217918

RESUMEN

OBJECTIVES: This study aimed to understand the potential reach of continence promotion intervention formats among incontinent women. METHODS: The Survey of the Health of Wisconsin conducts household interviews on a population-based sample. In 2016, 399 adult women were asked about incontinence and likelihood of participation in continence promotion via 3 formats: single lecture, interactive 3-session workshop, or online. Descriptive analyses compared women likely versus unlikely to participate in continence promotion. To understand format preferences, modified grounded theory was used to conduct and analyze telephone interviews. RESULTS: One hundred eighty-seven (76%) of 246 incontinent women reported being likely to attend continence promotion: 111 (45%) for a single lecture, 43 (17%) for an interactive 3-session workshop, and 156 (64%) for an online program. Obesity, older age, nonwhite race, prior health program participation, and Internet use for health information were associated with reported continence promotion participation. Cited advantages of a single lecture included convenience and ability to ask questions. A workshop offered accountability, hands-on learning, and opportunity to learn from others; online format offered privacy, convenience, and self-directed learning. CONCLUSIONS: Most incontinent women are willing to participate in continence promotion, especially online.


Asunto(s)
Incontinencia Fecal/psicología , Promoción de la Salud/métodos , Educación del Paciente como Asunto/métodos , Incontinencia Urinaria/psicología , Anciano , Femenino , Humanos , Persona de Mediana Edad , Prioridad del Paciente , Investigación Cualitativa , Encuestas y Cuestionarios
10.
Obstet Gynecol ; 134(3): 600-610, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31403596

RESUMEN

OBJECTIVE: To evaluate the effects of Mind Over Matter: Healthy Bowels, Healthy Bladder, a small-group intervention, on urinary and bowel incontinence symptoms among older women with incontinence. METHODS: In this individually randomized group treatment trial, women aged 50 years and older with urinary, bowel incontinence, or both, were randomly allocated at baseline to participate in Mind Over Matter: Healthy Bowels, Healthy Bladder immediately (treatment group) or after final data collection (waitlist control group). The primary outcome was urinary incontinence (UI) improvement on the Patient Global Impression of Improvement at 4 months. Validated instruments assessed incontinence, self-efficacy, depression, and barriers to care-seeking. Intent-to-treat analyses compared differences between groups. Target sample size, based on an anticipated improvement rate of 45% in treated women vs 11% in the control group, 90% power, type I error of 0.05, with anticipated attrition of 25%, was 110. RESULTS: Among 121 women randomized (62 treatment group; 59 control group), 116 (95%) completed the 4-month assessment. Most participants were non-Hispanic white (97%), with a mean age of 75 years (SD 9.2, range 51-98); 66% had attended some college. There were no significant between-group differences at baseline. At 4 months, 71% of treated women vs 23% of women in the control group reported improved UI on Patient Global Impression of Improvement (P<.001); 39% vs 5% were much improved (P<.001). Regarding bowel incontinence, 55% of treated women vs 27% of women in the control group improved on Patient Global Impression of Improvement (P<.005), with 35% vs 11% reporting much improvement (P<.005). Treated women improved significantly more than women in the control group on all validated instruments of incontinence severity, quality of life, and self-efficacy. Care-seeking rates were similar between groups. CONCLUSION: Participation in a small-group intervention improves symptoms of both urinary and bowel incontinence in older women. Mind Over Matter is a feasible model with potential to bring effective behavioral solutions to the community. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03140852.


Asunto(s)
Incontinencia Fecal/terapia , Psicoterapia de Grupo/métodos , Incontinencia Urinaria/terapia , Anciano , Anciano de 80 o más Años , Estudios de Factibilidad , Incontinencia Fecal/psicología , Femenino , Humanos , Análisis de Intención de Tratar , Persona de Mediana Edad , Atención Plena , Autoeficacia , Resultado del Tratamiento , Incontinencia Urinaria/psicología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA